These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
712 related items for PubMed ID: 15715890
1. Improvement of glucose tolerance in Zucker diabetic fatty rats by long-term treatment with the dipeptidyl peptidase inhibitor P32/98: comparison with and combination with rosiglitazone. Wargent E, Stocker C, Augstein P, Heinke P, Meyer A, Hoffmann T, Subramanian A, Sennitt MV, Demuth HU, Arch JR, Cawthorne MA. Diabetes Obes Metab; 2005 Mar; 7(2):170-81. PubMed ID: 15715890 [Abstract] [Full Text] [Related]
3. The development of overt diabetes in young Zucker Diabetic Fatty (ZDF) rats and the effects of chronic MCC-555 treatment. Pickavance L, Widdowson PS, King P, Ishii S, Tanaka H, Williams G. Br J Pharmacol; 1998 Oct; 125(4):767-70. PubMed ID: 9831913 [Abstract] [Full Text] [Related]
4. Combination of dipeptidylpeptidase IV inhibitor and low dose thiazolidinedione: preclinical efficacy and safety in db/db mice. Roy S, Khanna V, Mittra S, Dhar A, Singh S, Mahajan DC, Priyadarsiny P, Davis JA, Sattigeri J, Saini KS, Bansal VS. Life Sci; 2007 Jun 13; 81(1):72-9. PubMed ID: 17532347 [Abstract] [Full Text] [Related]
5. Synergistic improvement in insulin resistance with a combination of fenofibrate and rosiglitazone in obese type 2 diabetic mice. Choi WS, Lee JJ, Kim Y, Kim IS, Zhang WY, Myung CS. Arch Pharm Res; 2011 Apr 13; 34(4):615-24. PubMed ID: 21544727 [Abstract] [Full Text] [Related]
12. Comparison of the antidiabetic effects of brain-derived neurotrophic factor and thiazolidinediones in obese diabetic mice. Yamanaka M, Itakura Y, Tsuchida A, Nakagawa T, Noguchi H, Taiji M. Diabetes Obes Metab; 2007 Nov 13; 9(6):879-88. PubMed ID: 17924870 [Abstract] [Full Text] [Related]
13. Raw vegetable food containing high cyclo (his-pro) improved insulin sensitivity and body weight control. Song MK, Rosenthal MJ, Song AM, Yang H, Ao Y, Yamaguchi DT. Metabolism; 2005 Nov 13; 54(11):1480-9. PubMed ID: 16253637 [Abstract] [Full Text] [Related]
14. Efficacy of the dipeptidyl peptidase IV inhibitor isoleucine thiazolidide (P32/98) in fatty Zucker rats with incipient and manifest impaired glucose tolerance. Augstein P, Berg S, Heinke P, Altmann S, Salzsieder E, Demuth HU, Freyse EJ. Diabetes Obes Metab; 2008 Sep 13; 10(10):850-61. PubMed ID: 17970756 [Abstract] [Full Text] [Related]
16. Effects of the combination of dipeptidyl peptidase-IV inhibitor ASP8497 and antidiabetic drugs in streptozotocin-nicotinamide-induced mildly diabetic mice. Tahara A, Matsuyama-Yokono A, Nakano R, Someya Y, Hayakawa M, Shibasaki M. Eur J Pharmacol; 2009 Mar 01; 605(1-3):170-6. PubMed ID: 19171131 [Abstract] [Full Text] [Related]
18. A novel dipeptidyl peptidase-4 inhibitor, alogliptin (SYR-322), is effective in diabetic rats with sulfonylurea-induced secondary failure. Asakawa T, Moritoh Y, Kataoka O, Suzuki N, Takeuchi K, Odaka H. Life Sci; 2009 Jul 17; 85(3-4):122-6. PubMed ID: 19427871 [Abstract] [Full Text] [Related]
19. Discordance between intramuscular triglyceride and insulin sensitivity in skeletal muscle of Zucker diabetic rats after treatment with fenofibrate and rosiglitazone. Nadeau KJ, Ehlers LB, Aguirre LE, Reusch JE, Draznin B. Diabetes Obes Metab; 2007 Sep 17; 9(5):714-23. PubMed ID: 17697064 [Abstract] [Full Text] [Related]
20. Long-term treatment with the dipeptidyl peptidase IV inhibitor P32/98 causes sustained improvements in glucose tolerance, insulin sensitivity, hyperinsulinemia, and beta-cell glucose responsiveness in VDF (fa/fa) Zucker rats. Pospisilik JA, Stafford SG, Demuth HU, Brownsey R, Parkhouse W, Finegood DT, McIntosh CH, Pederson RA. Diabetes; 2002 Apr 17; 51(4):943-50. PubMed ID: 11916911 [Abstract] [Full Text] [Related] Page: [Next] [New Search]